• Non ci sono risultati.

European Oncology Leaders

N/A
N/A
Protected

Academic year: 2021

Condividi "European Oncology Leaders"

Copied!
5
0
0

Testo completo

(1)

European Oncology Leaders

The CancerFutures Collection 2001–2004

(2)

European Oncology Leaders The

CancerFutures Collection

2001–2004

With 140 Figures

(3)

Library of Congress Control Number:

2004113915

This work is subject to copyright. All rights are reserved, whether the whole or part of the material is concerned, specifi cally the rights of translation, reprinting, reuse of il- lustrations, recitation, broadcasting, repro- duction on microfi lms or in any other way, and storage in data banks. Duplication of this publication or parts thereof is permit- ted only under the provisions of the Ger- man Copyright Law of September 9, 1965, in its current version, and permission for use must always be obtained from Spring- er-Verlag. Violations are liable for prosecu- tion under the German Copyright Law.

Springer is a part

of Springer Science+Business Media springeronline.com

© Springer-Verlag Berlin Heidelberg 2005 and © ESO 2005

Printed in Germany

Professor Umberto Veronesi Dr. Kathy Redmond

European School of Oncology Viale Beatrice d’Este, 37 20122 Milan, Italy eso@esoncology.org www.cancerworld.org

The use of general descriptive names, regis- tered names, trademarks, etc. in this publi- cation does not imply, even in the absence of a specifi c statement, that such names are exempt from the relevant protective laws and regulations and therefore free for gen- eral use.

Product liability: The publishers cannot guarantee the accuracy of any information about dosage and application contained in this book. In every individual case the user must check such information by consulting the relevant literature.

Editor: Dr. Rolf Lange, Heidelberg Desk Editor: Hiltrud Wilbertz, Heidelberg Typsetting: SDS, Leimen

Production: Bernd Reichenthaler, Pro Edit GmbH, Heidelberg Printing: ABC-Druck, Heidelberg Binding: Schäffer, Grünstadt Printed on acid-free paper 27/3150/Re – 543210 ISBN 3-540-23658-9 Springer-Verlag

Berlin Heidelberg NewYork

(4)

Contents

Introduction 1

U. Veronesi, K. Redmond

Martine Piccart:

Medic and Musician 5 H. Saul

Gordon McVie:

Making Waves 13 H. Saul

Agnes Glaus:

Softly, Softly 21 H. Saul

Mariano Barbacid:

The Homecoming 29 H. Saul

Liisa Elovainio:

Tough on Tobacco 37 H. Saul

Franco Cavalli:

Rebel with (Several) Causes 47 H. Saul

Françoise Meunier:

Chameleon Chief 55 H. Saul

Cover Stories

Jean-Pierre Armand:

Sifting Sand 65 H. Saul

Silvia Marsoni:

The Go-Between 75 H. Saul

Harry Bartelink:

Putting Europe First 87 H. Saul

Nora Kearney:

Shaking up the Big House 95 J. McGuigan

Paris and Helen Kosmidis:

A Legend in Their Own Time 105 J. McGuigan

Jacek Jassem:

Reaching out From Gdansk 117 M.Beishon

Masterpieces

Interview with

Umberto Veronesi 131 M. Schneider

Maurice Tubiana:

The Fighting Spirit Behind Cancerology 137

M. Schneider and R. Brenner

V

Contents

(5)

Michael Baum:

Shooting Sacred Cows 141 H. Saul

Hans-Jörg Senn:

Championing Consensus 151 A. Wagstaff

Gianni Bonnadona:

Fighting for Every Llife 159 A. Wagstaff

Contents

VI

Contents

Riferimenti

Documenti correlati

• Active eye tracking technology – such as that present on the SPECTRALIS diagnostic imaging platform – helps avoid motion artefacts during OCT volume

This was possible since parallel imaging can be applied to practically all types of pulse sequences and imaging protocols, ranging from high-resolution morphological imaging

Institut für Experimentelle Hämatologie und Transfusionsmedizin der Universität, D-Bonn.. Brackmann,

Klinikum der Johann Wolfgang Goethe-Universität, Klinik für Kinderheilkunde III, Pädiatrische Hämatologie, Onkologie und Hämostaseologie, D-Frankfurt/Main K ROHN , J., Frau..

A su- periority compared to the postoperative radiochemotherapy, still recommended by the consensus guidelines of the National Institutes of Health and the German Cancer Society,

Various randomized controlled trials have shown that the colon J-pouch (CJP) as a rectal reservoir reconstruction leads to better early functional results compared to the

The second time period comprises 332 patients with rectal tumours (including adenomas) having undergone endosonography by six different examiners after introduction of this

Desk editor: Drthe Mennecke-Bhler, Heidelberg, Germany Production editor: Ingrid Haas, Heidelberg, Germany Typesetting: Strtz GmbH, Wrzburg, Germany Printing: Krips, Meppel,